“…Loss-of-function mutations in VPS53 have been associated with two forms of degenerative NDDs, autosomal recessive pontocerebellar hypoplasia type 2E (PCH2E, MIM #615851), characterized by a severe early-onset neurodegeneration with profound intellectual disability (ID), progressive microcephaly, spasticity, and early-onset epilepsy (Feinstein et al, 2014), and progressive encephalopathy with edema, hypsarrhythmia and optic atrophy (PEHO) characterized by a severe developmental delay, limb and facial edema, intractable epilepsy, optic atrophy and dysmorphic features (Hady-Cohen et al, 2018). Recently, a 6-year-old patient with severe global developmental delay, pontocerebellar abnormalities, microcephaly, hypotonia, epilepsy and several systemic and peripheral dysfunctions has been reported (Gershlick et al, 2019). This girl was found to carry compound heterozygous variants in VPS51 affecting both GARP and EARP complexes.…”